FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080274371> ?p ?o ?g. }

• W2080274371 endingPage "35028" @default.
• W2080274371 startingPage "35015" @default.
• W2080274371 abstract "The broadly neutralizing antibodies HIV 2F5 and 4E10, which bind to overlapping epitopes in the membrane-proximal external region of the fusion protein gp41, have been proposed to use a two-step mechanism for neutralization; first, they bind and preconcentrate at the viral membrane through their long, hydrophobic CDRH3 loops, and second, they form a high affinity complex with the protein epitope. Accordingly, mutagenesis of the CDRH3 can abolish their neutralizing activity, with no change in the affinity for the peptide epitope. We show here that we can mimic this mechanism by conjugating a cholesterol group outside of the paratope of an antibody. Cholesterol-conjugated antibodies bind to lipid raft domains on the membrane, and because of this enrichment, they show increased antiviral potency. In particular, we find that cholesterol conjugation (i) rescues the antiviral activity of CDRH3-mutated 2F5, (ii) increases the antiviral activity of WT 2F5, (iii) potentiates the non-membrane-binding HIV antibody D5 10–100-fold (depending on the virus strain), and (iv) increases synergy between 2F5 and D5. Conjugation can be made at several positions, including variable and constant domains. Cholesterol conjugation therefore appears to be a general strategy to boost the potency of antiviral antibodies, and, because membrane affinity is engineered outside of the antibody paratope, it can complement affinity maturation strategies. The broadly neutralizing antibodies HIV 2F5 and 4E10, which bind to overlapping epitopes in the membrane-proximal external region of the fusion protein gp41, have been proposed to use a two-step mechanism for neutralization; first, they bind and preconcentrate at the viral membrane through their long, hydrophobic CDRH3 loops, and second, they form a high affinity complex with the protein epitope. Accordingly, mutagenesis of the CDRH3 can abolish their neutralizing activity, with no change in the affinity for the peptide epitope. We show here that we can mimic this mechanism by conjugating a cholesterol group outside of the paratope of an antibody. Cholesterol-conjugated antibodies bind to lipid raft domains on the membrane, and because of this enrichment, they show increased antiviral potency. In particular, we find that cholesterol conjugation (i) rescues the antiviral activity of CDRH3-mutated 2F5, (ii) increases the antiviral activity of WT 2F5, (iii) potentiates the non-membrane-binding HIV antibody D5 10–100-fold (depending on the virus strain), and (iv) increases synergy between 2F5 and D5. Conjugation can be made at several positions, including variable and constant domains. Cholesterol conjugation therefore appears to be a general strategy to boost the potency of antiviral antibodies, and, because membrane affinity is engineered outside of the antibody paratope, it can complement affinity maturation strategies." @default.
• W2080274371 created "2016-06-24" @default.
• W2080274371 creator A5001910378 @default.
• W2080274371 creator A5003230006 @default.
• W2080274371 creator A5006353290 @default.
• W2080274371 creator A5013594065 @default.
• W2080274371 creator A5016262549 @default.
• W2080274371 creator A5022640226 @default.
• W2080274371 creator A5024209649 @default.
• W2080274371 creator A5027895154 @default.
• W2080274371 creator A5067435976 @default.
• W2080274371 creator A5070702245 @default.
• W2080274371 creator A5070764324 @default.
• W2080274371 creator A5073991440 @default.
• W2080274371 creator A5081606290 @default.
• W2080274371 creator A5091225024 @default.
• W2080274371 date "2014-12-01" @default.
• W2080274371 modified "2023-10-18" @default.
• W2080274371 title "Dramatic Potentiation of the Antiviral Activity of HIV Antibodies by Cholesterol Conjugation" @default.
• W2080274371 cites W1528872128 @default.
• W2080274371 cites W1635348995 @default.
• W2080274371 cites W1981981290 @default.
• W2080274371 cites W1983551402 @default.
• W2080274371 cites W1985748128 @default.
• W2080274371 cites W1993966288 @default.
• W2080274371 cites W2003317718 @default.
• W2080274371 cites W2005929028 @default.
• W2080274371 cites W2006712680 @default.
• W2080274371 cites W2006975604 @default.
• W2080274371 cites W2008497683 @default.
• W2080274371 cites W2013399404 @default.
• W2080274371 cites W2015611396 @default.
• W2080274371 cites W2021513648 @default.
• W2080274371 cites W2027284502 @default.
• W2080274371 cites W2035543619 @default.
• W2080274371 cites W2036114722 @default.
• W2080274371 cites W2049742199 @default.
• W2080274371 cites W2052202496 @default.
• W2080274371 cites W2055253070 @default.
• W2080274371 cites W2062204035 @default.
• W2080274371 cites W2070086938 @default.
• W2080274371 cites W2072746903 @default.
• W2080274371 cites W2074926933 @default.
• W2080274371 cites W2078901102 @default.
• W2080274371 cites W2078913377 @default.
• W2080274371 cites W2083094268 @default.
• W2080274371 cites W2091847883 @default.
• W2080274371 cites W2099171570 @default.
• W2080274371 cites W2101600215 @default.
• W2080274371 cites W2103562758 @default.
• W2080274371 cites W2106184632 @default.
• W2080274371 cites W2108422942 @default.
• W2080274371 cites W2111902258 @default.
• W2080274371 cites W2115063969 @default.
• W2080274371 cites W2116150122 @default.
• W2080274371 cites W2122188063 @default.
• W2080274371 cites W2122710825 @default.
• W2080274371 cites W2127979877 @default.
• W2080274371 cites W2131317050 @default.
• W2080274371 cites W2134866108 @default.
• W2080274371 cites W2136558879 @default.
• W2080274371 cites W2140199226 @default.
• W2080274371 cites W2141735502 @default.
• W2080274371 cites W2143312620 @default.
• W2080274371 cites W2145937569 @default.
• W2080274371 cites W2154836432 @default.
• W2080274371 cites W2162546635 @default.
• W2080274371 cites W2165055542 @default.
• W2080274371 cites W2166216392 @default.
• W2080274371 cites W2166859411 @default.
• W2080274371 cites W272400546 @default.
• W2080274371 cites W3147919323 @default.
• W2080274371 doi "https://doi.org/10.1074/jbc.m114.591826" @default.
• W2080274371 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4263897" @default.
• W2080274371 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25342747" @default.
• W2080274371 hasPublicationYear "2014" @default.
• W2080274371 type Work @default.
• W2080274371 sameAs 2080274371 @default.
• W2080274371 citedByCount "17" @default.
• W2080274371 countsByYear W20802743712015 @default.
• W2080274371 countsByYear W20802743712016 @default.
• W2080274371 countsByYear W20802743712017 @default.
• W2080274371 countsByYear W20802743712018 @default.
• W2080274371 countsByYear W20802743712019 @default.
• W2080274371 countsByYear W20802743712021 @default.
• W2080274371 countsByYear W20802743712022 @default.
• W2080274371 countsByYear W20802743712023 @default.
• W2080274371 crossrefType "journal-article" @default.
• W2080274371 hasAuthorship W2080274371A5001910378 @default.
• W2080274371 hasAuthorship W2080274371A5003230006 @default.
• W2080274371 hasAuthorship W2080274371A5006353290 @default.
• W2080274371 hasAuthorship W2080274371A5013594065 @default.
• W2080274371 hasAuthorship W2080274371A5016262549 @default.
• W2080274371 hasAuthorship W2080274371A5022640226 @default.
• W2080274371 hasAuthorship W2080274371A5024209649 @default.
• W2080274371 hasAuthorship W2080274371A5027895154 @default.
• W2080274371 hasAuthorship W2080274371A5067435976 @default.
• W2080274371 hasAuthorship W2080274371A5070702245 @default.

• next